AlphaFold predicted structure
ELAC2 · Q9BQ52

Mean pLDDT
82.8/ 100
Confident
826 residues
Confidence breakdown
- Very high(≥ 90)62%
- Confident(70–90)20%
- Low(50–70)3%
- Very low(< 50)15%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
elaC ribonuclease Z 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPaediatric or syndromic cardiomyopathy
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomal+2 more panels — install the extension to see the full list inline on any page.
combined oxidative phosphorylation defect type 17
prostate cancer, hereditary, 2
hereditary disease
Intellectual disability
inborn mitochondrial metabolism disorder
mitochondrial disease
mitochondrial complex I deficiency, nuclear type 1
ovarian cancer
viral pneumonia
type 2 diabetes mellitus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Zinc phosphodiesterase ELAC protein 2
Zinc phosphodiesterase, which displays mitochondrial tRNA 3'-processing endonuclease activity. Involved in tRNA maturation, by removing a 3'-trailer from precursor tRNA (PubMed:21593607). Associates with mitochondrial DNA complexes at the nucleoids to initiate RNA processing and ribosome assembly (PubMed:24703694)
ELAC2 · Q9BQ52

Mean pLDDT
82.8/ 100
Confident
826 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0